𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Parkinson's disease mortality and the industrial use of heavy metals in Michigan

✍ Scribed by Benjamin A. Rybicki; Christine Cole Johnson; Jane Uman; Jay M. Gorell


Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
597 KB
Volume
8
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Parkinson's disease (PD) mortality rates in Michigan counties for 1986–1988 were calculated with respect to potential heavey metal exposure (iron, zinc, copper, mercury, magnesium, and manganese) from industry based on recent census data. Individuals were counted as a PD death if the diagnosis was listed as an “underlying” or “related” cause of death on the death certificate. Counties with an industry in the paper, chemical, iron, or copper related‐industrial categories (ICs) had statiscally significantly (p < 0.05) higher PD death rates than counties without these industries. Significant correlations of chemical (r~s~ =0.22;p = 0.05), paper (r~s~ =0.22;p = 0.05) and iron (r~s~ =0.29;p = 0.008) industry densities with PD death rates were also present. Counties were divided into high (>15/100,000 individuals 45 years old and over) and low (< = 15/100.000) PD death rate counties by cluster analysis. Geographically, counties with high PD mortality were located mainly in the southern half of the lower peninsula and eastern half of the upper peninsula; low PD death rate counties formed two distinct clusters in the western edge of the upper peninsula and the north‐central portion of the lower peninsula. Other possible risk factors that may explain the varied distribution of PD death rates in Michigan were examined. Those significantly correlated with PD mortality included population density (r~s~ =0.31;p= 0.005), farming density (r~s~= 0.25;p =0.02), and well water use (r~s~ =−0.24;p =0.03). These ecologic findings suggest a geographic association between PD mortality and the industrial use of heavy metals.


📜 SIMILAR VOLUMES


Smokeless tobacco use and the risk of Pa
✍ Eilis J. O'Reilly; Marji L. McCullough; Ann Chao; S. Jane Henley; Eugenia E. Cal 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 1 views

## Abstract We examined the association between smokeless tobacco use and Parkinson's disease (PD) mortality as assessed by death certificate in a prospective cohort of 95,981 never‐smoking men. In this cohort, smokeless tobacco use is inversely associated with PD mortality, with an age‐adjusted ri

Mortality in patients with Parkinson's d
✍ Michael W.M. Schüpbach; Marie Laure Welter; Anne Marie Bonnet; Alexis Elbaz; Bra 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 1 views

## Abstract Subthalamic nucleus (STN) stimulation improves motor disability and quality of life in patients with advanced Parkinson's disease (PD). Short‐term mortality is low, but little is known about long‐term mortality. We assessed mortality and causes of death in 171 consecutive PD patients tr

Rating impairment and disability in Park
✍ Dr. J. J. van Hilten; A. D. van der Zwan; A. H. Zwinderman; R. A. C. Roos 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 411 KB 👁 1 views

## Abstract Although the Unified Parkinson's Disease Rating Scale (UPDRS) is widely used to monitor disease progression and drug efficacy, no attempts have been made to evaluate its scientific and clinical quality. Poor clinical sensibility of items in the activities of daily living (ADL) section a